{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:08:01Z","timestamp":1784092081567,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The optimal decompression strategy for patients with initially non-resectable obstructive colorectal cancer undergoing conversion intent treatment remains unclear. This study compared diversion ostomy (DO) and self-expanding metal stent (SEMS) placement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 115 patients with initially non-resectable obstructive colorectal cancer, who were treated between June 2021 and June 2025, were retrospectively reviewed. Sixty-two patients underwent DO, and 53 underwent SEMS as the initial decompression strategy. After decompression, patients received oxaliplatin and oral capecitabine (i.e., \u201cCAPEOX\u201d)- or folinic acid, fluorouracil, and oxaliplatin (i.e., \u201cFOLFOX\u201d)-based systemic therapy with targeted therapy, with or without immunotherapy, according to molecular and immunohistochemical findings. Clinical outcomes, nutritional and inflammatory indices, tumor response, subsequent resection, and overall survival (OS) were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DO was associated with a significantly higher rate of achievement of Colorectal Obstruction Scoring System (CROSS) score 3 than SEMS (85.5% versus [vs.] 47.2%; P&amp;lt;0.001), and a higher number of chemotherapy cycles (median, 6 vs. 2; P&amp;lt;0.001). Post-treatment nutritional and inflammatory profiles were more favorable in the DO group, with higher Prognostic Nutritional Index (\u226545) rates and lower platelet-to-lymphocyte and neutrophil-to lymphocyte ratios (all P \u2264 0.005). The objective response and subsequent resection rates were significantly higher in the DO group than that in the SEMS group (69.4% vs. 30.2%; P&amp;lt;0.001), as was the subsequent resection rate (69.4% vs. 30.2%; P&amp;lt;0.001), respectively. Kaplan\u2013Meier analysis revealed significantly longer OS in the DO group, with a median survival of 27.8 vs. 10.3 months (P&amp;lt;0.0001). In multivariate analysis, SEMS remained independently associated with worse OS than DO (hazard ratio 2.231 [95% confidence interval 1.345\u20133.842; P\u00a0=\u00a00.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with initially non-resectable obstructive colorectal cancer treated with conversion intent, DO was associated with better decompression, improved treatment tolerance, higher resection rates, and longer survival than SEMS placement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1881728","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:44:56Z","timestamp":1784090696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Fengbin","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Xiamen Humanity Hospital, Fuiian Medical University","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Xiamen Humanity Hospital, Fuiian Medical University","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Xiamen Humanity Hospital, Fuiian Medical University","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Xiamen Humanity Hospital, Fuiian Medical University","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing incidence of early-onset colorectal cancer","volume":"386","author":"Sinicrope","year":"2022","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100805","article-title":"Colorectal liver metastasis pathomics model: Integrating single-cell and spatial transcriptome analysis with pathomics for predicting liver metastasis in colorectal cancer","volume":"38","author":"Zeng","year":"2025","journal-title":"Mod Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17809-5","article-title":"Genomic and clinical predictors of conversion in initially unresectable colorectal cancer liver metastases","volume":"32","author":"Zuo","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00423-024-03374-0","article-title":"Prognosis and predictive factors of conversion surgery for initially unresectable advanced colorectal cancer","volume":"409","author":"Ohira","year":"2024","journal-title":"Langenbecks Arch Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040821","article-title":"Malignant acute colonic obstruction: Multidisciplinary approach for endoscopic management","volume":"16","author":"Mauro","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v13.i12.943","article-title":"Oncologic safety of colonic stenting as a bridge to surgery in left-sided Malignant colonic obstruction: Current evidence and prospects","volume":"13","author":"Pattarajierapan","year":"2022","journal-title":"World J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00384-023-04489-4","article-title":"Which treatment strategy is optimal for acute left-sided Malignant colonic obstruction? A Bayesian meta-analysis","volume":"38","author":"Ouyang","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/den.13798","article-title":"Acute colonic obstruction within a congenital Bochdalek diaphragmatic hernia following colonoscopy","volume":"32","author":"Ventham","year":"2020","journal-title":"Dig Endosc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-021-00355-2","article-title":"Comparison of the prognosis of four different treatment strategies for acute left Malignant colonic obstruction: a systematic review and network meta-analysis","volume":"16","author":"Tan","year":"2021","journal-title":"World J Emerg Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-022-01008-5","article-title":"Perioperative chemotherapy for liver metastasis of colorectal cancer: Lessons learned and future perspectives","volume":"23","author":"Riesco-Martinez","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i7.107438","article-title":"Current status and advances in the treatment of colorectal cancer with liver metastases","volume":"16","author":"Liu","year":"2025","journal-title":"World J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409329","article-title":"Targeting metabolic adaptation of colorectal cancer with vanadium-doped nanosystem to enhance chemotherapy and immunotherapy","volume":"12","author":"Cheng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1595580","article-title":"FOLFOXIRI plus biologics in advanced colorectal cancer","volume":"19","author":"Garc\u00eda-Alfonso","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110020","article-title":"Muscle-specific strength predicts postoperative complications and survival in patients undergoing curative colectomy for colorectal cancer","volume":"51","author":"Zhai","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002291","article-title":"The contemporary probability of occult colorectal cancer in patients with colitis-related dysplasia undergoing colectomy","volume":"118","author":"Boparai","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00228-5","article-title":"Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study","volume":"8","author":"Eikenboom","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-018-3990-8","article-title":"Urgent management of obstructing colorectal cancer: Divert, stent, or resect","volume":"23","author":"Malakorn","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12957-018-1509-0","article-title":"Comparative study between colonic metallic stent and anal tube decompression for Japanese patients with left-sided Malignant large bowel obstruction","volume":"16","author":"Kagami","year":"2018","journal-title":"World J Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v14.i11.704","article-title":"Self-expanding metal stent placement and pathological alterations among obstructive colorectal cancer cases","volume":"14","author":"Kosumi","year":"2022","journal-title":"World J Gastrointest Endosc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.10.040","article-title":"Structural optimization and in vivo evaluation of a colorectal stent with anti-migration and anti-tumor properties","volume":"154","author":"Cai","year":"2022","journal-title":"Acta Biomater"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13017-024-00543-w","article-title":"Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago","volume":"19","author":"Perrone","year":"2024","journal-title":"World J Emerg Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/won.0000000000000424","article-title":"Ostomy creation for palliative care of patients with nonresectable colorectal cancer and bowel obstruction","volume":"45","author":"Pickard","year":"2018","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2017.05.008","article-title":"Clinical outcomes of self-expandable metal stent (SEMS) placement as palliative treatment for Malignant colorectal obstruction: A single-center study from Japan","volume":"19","author":"Nitta","year":"2017","journal-title":"Ann Med Surg (Lond)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/1751-2980.13156","article-title":"Efficacy of neoadjuvant CapeOX\/mFOLFOX6 without radiation for patients with baseline resectable mid-low locally advanced rectal cancer","volume":"23","author":"Zhao","year":"2022","journal-title":"J Dig Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175434","article-title":"The prognostic nutritional index (PNI): A new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma","volume":"12","author":"Ellez","year":"2023","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1623899","article-title":"The predictive role of peripheral serum inflammatory markers NLR, PLR, and LMR in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis","volume":"16","author":"Tan","year":"2025","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1186\/s12885-022-10125-1","article-title":"Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11864-018-0563-8","article-title":"Metastatic colorectal cancer to the peritoneum: Current treatment options","volume":"19","author":"Vassos","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2017.11.010","article-title":"Surgical treatment of metastatic colorectal cancer","volume":"27","author":"Chakedis","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000111483","article-title":"Advances in chemotherapy against advanced or metastatic colorectal cancer","author":"Omura","year":"2008","journal-title":"Digestion"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57030268","article-title":"Current status of the self-expandable metal stent as a bridge to surgery versus emergency surgery in colorectal cancer: Results from an updated systematic review and meta-analysis of the literature","volume":"57","author":"Cirocchi","year":"2021","journal-title":"Med (Kaunas)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-022-02575-8","article-title":"A decreased preoperative platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer","volume":"53","author":"Sato","year":"2023","journal-title":"Surg Today"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-25-0679","article-title":"A plastic EMP1+ to LGR5+ cell state conversion as a bypass to KRASG12D pharmacologic inhibition in metastatic colorectal cancer","volume":"16","author":"Centonze","year":"2026","journal-title":"Cancer Discov"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0278","article-title":"FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: A systematic review and pooled analysis","volume":"3","author":"Tomasello","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1881728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:45:01Z","timestamp":1784090701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1881728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":35,"alternative-id":["10.3389\/fonc.2026.1881728"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1881728","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1881728"}}